EASYCARE'S CEO, LARRY DORFMAN, TO PRESENT IN A

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
EASYCARE'S CEO, LARRY DORFMAN, TO PRESENT IN A COMPLIMENTARY WEBINAR HIGHLIGHTING BEST PRACTICES IN MIDST OF INCREASING REGULATION SCRUTINY ON F&I AUTO INDUSTRY

ATLANTA, Dec. 14, 2015 (GLOBE NEWSWIRE) -- A complimentary webinar, "Focus on Products", will be presented via Automotive News on Wednesday, Dec. 16, at 2 pm ET, shedding light on the most effective ways for dealers to increase their back-end profits by shifting their focus on F &I: the leading F &I benefits, the most effective selling tactics, and ways to price them appropriately in accordance with the Consumer Financial Protection Bureau regulations. The 1-hour webinar will be presented by EasyCare's CEO Larry Dorfman, alongside JM &A Group's Vice President and General Manager, Mike Casey. Moderators include Automotive News' Hannah Lutz and Jim Treece. Talking points that will be covered include the importance of increasing the value received by the customer for the F &I dollar, how to successfully introduce the value of the F &I benefits early in the buying process, and how to increase product penetration and overall profit.   Registration is open to the public, and accessible by clicking here . If unable to attend the webinar, a recording will be available for those who register.   About EasyCare®

EasyCare's mission is to "help others succeed". Since 1984, the company has provided leading-edge benefits that have helped nationwide dealers deliver an outstanding ownership experience to over 7 million customers. EasyCare provides the only F &I benefits that are deemed a "MOTOR TREND Recommended Best Buy" for franchised dealers, in addition to a full suite of training programs, management development and proprietary software. For more information, please visit easycare.com .

Ashley Braswell Director of PR & Communications 678-615-1142

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading